✦ LIBER ✦

Interferons in the treatment of multiple myeloma

✍ Scribed by M. Robert Cooper; Charles E. Welander

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 631 KB
Volume: 59
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870201)59:3+<594::aid-cncr2820591303>3.0.co;2-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferons in the treatment of multiple

Interferons in the treatment of multiple myeloma

✍ R. Ohno 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 652 KB

A review of the clinical studies in which interferons have been involved has shown that they may have a role in the treatment of multiple myeloma. Twelve studies, each of which involved at least 10 evaluable cases (352 in total) with various dose schedules involving leukocyte, lymphoblastoid and rec

The addition of interferon or high dose

The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma : Phase III Eastern Cooperative Oncology Group clinical trial EST 9486

✍ Martin M. Oken; Traci Leong; Raymond E. Lenhard Jr.; Philip R. Greipp; Neil E. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. Interferon (IFN) has demonstrated activity in the treatment of patients with multiple myeloma. A previous Eastern Cooperative Oncology Group (ECOG) study suggested that the rates of complete response (CR) and survival were increased with a regimen that alternated IFN with chemothera

Treatment of multiple myeloma with recom

Treatment of multiple myeloma with recombinant interferon alfa-2a

✍ Ryuzo Ohno; Kiyoji Kimura 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

Combination of interferon and dexamethas

Combination of interferon and dexamethasone in refractory multiple myeloma

✍ J. F. San Miguel; M. Moro; J. Bladé; L. Guerras; J. Hernandez; R. Jimenez-Galind 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

The present pilot study was designed to analyse the efficacy and toxicity of the association of interferon (IFN) and dexamethasone (Dx) in 32 resistant and relapsed myeloma patients. Among the evaluable cases, 15 (68 per cent) responded to treatment (32 per cent achieved an objective respons4R-and 3

Randomized trial of α-interferon or dexa

Randomized trial of α-interferon or dexamethasone as maintenance treatment for multiple myeloma

✍ Raymond Alexanian; Donna Weber; Meletios Dimopoulos; Kay Delasalle; Terry L. Smi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

Treatment of multiple myeloma in patient

Treatment of multiple myeloma in patients with Gaucher disease

✍ Maciej Machaczka; Richard Lerner; Monika Klimkowska; Hans Hägglund 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views